Editas Medicine, Inc. (EDIT)

2.19 -0.14 (-6.01%) USD  |  NASDAQ  |  Dec 23, 16:00
2.19 0.00 (0.00%) Pre-Market: 08:53
More

Editas Medicine SG&A Expense (TTM): 54.90M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. 96.37M
Arcutis Biotherapeutics, Inc. 253.18M
Daré Bioscience, Inc. 9.228M
Cogent Biosciences, Inc. 51.34M
Janux Therapeutics, Inc. 39.13M